News

Business Insider's July 30 virtual event features executives talking about procurement innovation strategies. The panel ...
Risks to BMY include potential for tariffs to raise costs of drugs manufactured outside of the U.S. Moreover, drug pricing ...
Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...
Long-term follow-up data show that the preventive effects of short-term treatment with abatacept disappear after 4-5 years.
Looking into the current session, Bristol-Myers Squibb Inc. BMY shares are trading at $47.05, after a 1.22% drop. Over the ...
Bristol Myers Squibb (BMY) closed at $47.51 in the latest trading session, marking a +2.64% move from the prior day.
Bristol Myers Squibb to cut 68 jobs in Lawrenceville as part of a broader restructuring effort aiming to slash $2B in costs ...
Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol ...